|
Status |
Public on Mar 26, 2019 |
Title |
TCF21 and AP-1 interact through epigenetic modifications to regulate coronary artery disease gene expression [ChIP-Seq] |
Organism |
Homo sapiens |
Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
|
Summary |
The majority of genetic variation associated with coronary artery disease (CAD) resides in non- coding regions that are expected to involve transcriptional and epigenetic mechanisms of gene expression. We have identified a transcriptional network downstream of the CAD associated transcription factor (TF) TCF21 and provide evidence for TCF21 colocalization and co- regulation with the activator protein-1 (AP-1) complex in disease loci. We show that TCF21 and AP-1 regulate expression of two causal CAD genes, SMAD3 and CDKN2B-AS1, in part by interactions with histone acetyltransferases and deacetylases. Genome-wide, TCF21 and AP-1 are jointly localized, regulate chromatin accessibility, and are enriched in CAD loci. These data show that the known chromatin remodeling and pioneer functions of AP-1 are a pervasive aspect of epigenetic control of transcription and thus risk in CAD associated loci, and that interaction of AP-1 with TCF21 to control epigenetic features contributes to the genetic risk in loci where they colocalize.
|
|
|
Overall design |
Human coronary artery smooth muscle cells (HCASMC) grown in serum were evaluated with an antibody to H3K27ac, or input control with siRNA of JUN, shRNA of TCF21 or control knockdown.
|
|
|
Contributor(s) |
Zhao Q, Wirka R, Nguyen T, Nagao M, Cheng P, Miller CL, Kim JB, Pjanic M, Quertermous T |
Citation(s) |
31014396 |
|
Submission date |
Nov 20, 2018 |
Last update date |
May 09, 2019 |
Contact name |
Thomas Quertermous |
E-mail(s) |
[email protected]
|
Phone |
650-723-5012
|
Organization name |
Stanford University
|
Department |
Medicine Cardiology
|
Lab |
Quertermous
|
Street address |
300 Pasteur Drive
|
City |
Stanford |
State/province |
CA |
ZIP/Postal code |
94305 |
Country |
USA |
|
|
Platforms (1) |
|
Samples (6)
|
|
This SubSeries is part of SuperSeries: |
GSE122758 |
TCF21 and AP-1 interact through epigenetic modifications to regulate coronary artery disease gene expression |
|
Relations |
BioProject |
PRJNA506320 |
SRA |
SRP170064 |